The effects of triclabendazole on breast cancer cells could partly reverse by a reactive oxygen scavenger NAC and caspase-3–specific inhibitor Ac-DEVD-CHO, which suggests triclabendazole induced pyroptosis through increasing the levels of ROS and activating caspase-3. The gene discussed is CASP3; the disease is breast cancer.